JMG Corporate
Enzo Biochem says ransomware attack exposed clinical test data of 2.5 million patients
Enzo Biochem, a New York-based biotechnology company, has confirmed that a ransomware attack exposed the clinical test information of almost 2.5 million patients. Enzo, which manufactures and sells DNA-based tests to detect viral and bacterial diseases including COVID-19 and cancer,
June 1, 2023